| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
|
1,987 |
1,858 |
$367K |
| 99283 |
|
1,926 |
1,829 |
$286K |
| 99285 |
|
1,302 |
1,220 |
$263K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,403 |
3,143 |
$32K |
| 93005 |
|
724 |
667 |
$16K |
| 80053 |
|
2,317 |
2,174 |
$16K |
| 96374 |
|
883 |
808 |
$15K |
| 85025 |
|
2,144 |
1,935 |
$12K |
| J3490 |
Unclassified drugs |
4,447 |
2,344 |
$12K |
| 71046 |
|
222 |
211 |
$6K |
| 82306 |
|
212 |
204 |
$4K |
| 96372 |
|
749 |
684 |
$4K |
| 70450 |
|
24 |
24 |
$4K |
| 80061 |
|
370 |
357 |
$3K |
| 96375 |
|
612 |
551 |
$3K |
| 71045 |
|
175 |
158 |
$3K |
| 83036 |
|
560 |
547 |
$3K |
| 84484 |
|
541 |
498 |
$3K |
| 84443 |
|
254 |
243 |
$3K |
| 87389 |
|
122 |
116 |
$2K |
| 85027 |
|
707 |
681 |
$2K |
| G0378 |
Hospital observation service, per hour |
18 |
12 |
$2K |
| 82607 |
|
178 |
171 |
$2K |
| 81025 |
|
295 |
274 |
$2K |
| 96361 |
|
355 |
316 |
$1K |
| 80307 |
|
36 |
29 |
$1K |
| 82746 |
|
136 |
130 |
$1K |
| 80048 |
|
265 |
250 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
592 |
545 |
$1K |
| 81001 |
|
459 |
437 |
$1K |
| 87880 |
|
87 |
83 |
$971.04 |
| 83540 |
|
191 |
181 |
$892.77 |
| 83690 |
|
155 |
148 |
$737.88 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
209 |
193 |
$737.27 |
| 94640 |
|
30 |
27 |
$699.90 |
| 81003 |
|
334 |
319 |
$590.01 |
| 99282 |
|
12 |
12 |
$563.80 |
| 82803 |
|
26 |
24 |
$531.92 |
| 84466 |
|
62 |
60 |
$527.90 |
| 87081 |
|
88 |
83 |
$488.24 |
| 96365 |
|
38 |
37 |
$487.27 |
| 96127 |
|
337 |
326 |
$455.41 |
| 83605 |
|
26 |
24 |
$199.65 |
| 83735 |
|
63 |
55 |
$192.05 |
| 80076 |
|
52 |
52 |
$179.82 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
71 |
65 |
$154.35 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
28 |
26 |
$89.23 |
| 94760 |
|
28 |
12 |
$59.68 |
| 99406 |
|
14 |
14 |
$37.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$14.86 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
25 |
25 |
$9.34 |
| A9270 |
Non-covered item or service |
432 |
230 |
$0.00 |
| 90686 |
|
50 |
49 |
$0.00 |